Clinical study of early warning of toxic and side effects of chemotherapy in ovarian cancer based on patient-reported outcomes (PRO)

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500095728

Enrollment

Unknown

Registered

2025-01-13

Start date

2025-01-16

Completion date

Unknown

Last updated

2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian cancer

Interventions

Experimental group: Symptoms were monitored using the patient-reported outcome electronic platform

control group:Symptoms were not monitored using the patient-reported outcome electronic platform

Eligibility

Sex/Gender

Female

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with ovarian cancer (comprehensive staged surgery in the early stage and tumor cell reduction in the late stage) and adjuvant chemotherapy after surgery.

Exclusion criteria

Exclusion criteria: Patients who do not want to participate

Design outcomes

Primary

Measure	Time frame
toxic and side effects of chemotherapy;	—

Secondary

Measure	Time frame
Serum CA125 and HE4;tumor necrosis factor, TNF)-a,(interleukin,IL)-6;(interferon,IFN)-?;	—

Countries

China

Contacts

Public ContactYuanyuan Zhang

Affiliated Hospital of North Sichuan Medical College

573385234@qq.com+86 139 9078 0282

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026